2022 marks the 30th anniversary of Leinco Technologies! As the year comes to a close, we would like to thank our customers for their continued support by offering 22% off selected antibodies through December 31st, 2022. Interested in hearing what exactly 30 years of Leinco means to some of our customers and staff? Watch our special anniversary video below.

Selected sale items include:

  • in vivo PLATINUM™ and GOLD™ functional grade antibodies
  • Recombinant human biosimilar antibodies for research
  • Immune checkpoint blockade antibodies
  • SARS CoV-2 (COVID-19) antibodies
  • Mouse immune cell specific depletion antibodies
 

Products are for research use only. Cannot be combined with other offers or promotions. No promo code is needed. The sale price is indicated on the product page and when added to the cart. No minimum purchase is required. Offer valid for non-commercial direct end users in USA and Canada.  If you are a customer outside these specified countries, please inquire about local promotions from your local field representative or a distributor. Other restrictions may apply. 

30th Anniversary Video

Format
Reactive Species
Host Species
Reported Applications
Clone
Category

Can't find what you're looking for?

Contact Leinco Technologies

10 per page
Sort by

Toggle Details

Showing 1 – 10 of 361 results Showing all 361 results Showing the single result No results found
- -
- -
Name
Applications ?
Prod No.
Clone
Pkg. Size / Quantity
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
CyTOF®
,
ELISA
,
FC
,
IHC
LT1500
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
FC
,
IHC
LT1503
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
ELISA
,
FC
LT1501
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
FC
,
IHC
LT1511
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
ELISA
,
FC
,
IHC
LT1502
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
FC
,
IHC
LT1504
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
CyTOF®
,
ELISA
,
FC
,
IHC
LT1505
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
ELISA
,
FC
LT1506
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
ELISA
,
FC
LT1507
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
DEFA5; DEF5; HD-5
Reactivity:
Human
Immunogen:
Recombinant Human HD5 (aa 20-94).
Dot
,
ELISA
,
IHC FFPE
,
in vivo
,
WB
D405
8C8
Max:
Min: 1
Step: 1
1237